These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 17093136)
1. 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes inhibit growth, induce apoptosis, and decrease the androgen receptor in LNCaP prostate cancer cells through peroxisome proliferator-activated receptor gamma-independent pathways. Chintharlapalli S; Papineni S; Safe S Mol Pharmacol; 2007 Feb; 71(2):558-69. PubMed ID: 17093136 [TBL] [Abstract][Full Text] [Related]
2. 1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes are peroxisome proliferator-activated receptor gamma agonists but decrease HCT-116 colon cancer cell survival through receptor-independent activation of early growth response-1 and nonsteroidal anti-inflammatory drug-activated gene-1. Chintharlapalli S; Papineni S; Baek SJ; Liu S; Safe S Mol Pharmacol; 2005 Dec; 68(6):1782-92. PubMed ID: 16155208 [TBL] [Abstract][Full Text] [Related]
3. 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce apoptosis and inhibit renal cell carcinoma growth. York M; Abdelrahim M; Chintharlapalli S; Lucero SD; Safe S Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6743-52. PubMed ID: 18006776 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of bladder tumor growth by 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes: a new class of peroxisome proliferator-activated receptor gamma agonists. Kassouf W; Chintharlapalli S; Abdelrahim M; Nelkin G; Safe S; Kamat AM Cancer Res; 2006 Jan; 66(1):412-8. PubMed ID: 16397256 [TBL] [Abstract][Full Text] [Related]
5. Methyl 2-cyano-3,11-dioxo-18 beta-olean-1,12-dien-30-oate is a peroxisome proliferator-activated receptor-gamma agonist that induces receptor-independent apoptosis in LNCaP prostate cancer cells. Papineni S; Chintharlapalli S; Safe S Mol Pharmacol; 2008 Feb; 73(2):553-65. PubMed ID: 17989348 [TBL] [Abstract][Full Text] [Related]
6. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways. Vanderlaag K; Su Y; Frankel AE; Grage H; Smith R; Khan S; Safe S Breast Cancer Res Treat; 2008 May; 109(2):273-83. PubMed ID: 17624585 [TBL] [Abstract][Full Text] [Related]
7. 1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce peroxisome proliferator-activated receptor gamma-mediated growth inhibition, transactivation, and differentiation markers in colon cancer cells. Chintharlapalli S; Smith R; Samudio I; Zhang W; Safe S Cancer Res; 2004 Sep; 64(17):5994-6001. PubMed ID: 15342379 [TBL] [Abstract][Full Text] [Related]
8. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms. Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539 [TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer. Nagata D; Yoshihiro H; Nakanishi M; Naruyama H; Okada S; Ando R; Tozawa K; Kohri K Cancer Detect Prev; 2008; 32(3):259-66. PubMed ID: 18789607 [TBL] [Abstract][Full Text] [Related]
10. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells. Murthy S; Agoulnik IU; Weigel NL Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350 [TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor gamma-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation. Yang CC; Wang YC; Wei S; Lin LF; Chen CS; Lee CC; Lin CC; Chen CS Cancer Res; 2007 Apr; 67(7):3229-38. PubMed ID: 17409431 [TBL] [Abstract][Full Text] [Related]
12. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through PPARgamma-dependent and PPARgamma-independent pathways. Chintharlapalli S; Papineni S; Safe S Mol Cancer Ther; 2006 May; 5(5):1362-70. PubMed ID: 16731770 [TBL] [Abstract][Full Text] [Related]
13. 3,3'-diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5. Abdelrahim M; Newman K; Vanderlaag K; Samudio I; Safe S Carcinogenesis; 2006 Apr; 27(4):717-28. PubMed ID: 16332727 [TBL] [Abstract][Full Text] [Related]
14. 2-Cyano-3,12-dioxoolean-1,9-dien-28-oic acid and related compounds inhibit growth of colon cancer cells through peroxisome proliferator-activated receptor gamma-dependent and -independent pathways. Chintharlapalli S; Papineni S; Konopleva M; Andreef M; Samudio I; Safe S Mol Pharmacol; 2005 Jul; 68(1):119-28. PubMed ID: 15798084 [TBL] [Abstract][Full Text] [Related]
15. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA). Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076 [TBL] [Abstract][Full Text] [Related]
16. Antiandrogenic and growth inhibitory effects of ring-substituted analogs of 3,3'-diindolylmethane (ring-DIMs) in hormone-responsive LNCaP human prostate cancer cells. Abdelbaqi K; Lack N; Guns ET; Kotha L; Safe S; Sanderson JT Prostate; 2011 Sep; 71(13):1401-12. PubMed ID: 21321979 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts. Chiu FL; Lin JK Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333 [TBL] [Abstract][Full Text] [Related]
18. 1,1-bis(3'-indolyl)-1-(p-methoxyphenyl)methane activates Nur77-independent proapoptotic responses in colon cancer cells. Cho SD; Lei P; Abdelrahim M; Yoon K; Liu S; Guo J; Papineni S; Chintharlapalli S; Safe S Mol Carcinog; 2008 Apr; 47(4):252-63. PubMed ID: 17957723 [TBL] [Abstract][Full Text] [Related]
19. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression. Yang Q; Titus MA; Fung KM; Lin HK J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593 [TBL] [Abstract][Full Text] [Related]
20. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts. Liu CM; Lo YC; Tai MH; Wu BN; Wu WJ; Chou YH; Chai CY; Huang CH; Chen IJ Prostate; 2009 May; 69(6):610-23. PubMed ID: 19143029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]